0001096906-12-000157.txt : 20120202 0001096906-12-000157.hdr.sgml : 20120202 20120202152709 ACCESSION NUMBER: 0001096906-12-000157 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20120202 DATE AS OF CHANGE: 20120202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UTAH MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0000706698 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870342734 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-153361 FILM NUMBER: 12565789 BUSINESS ADDRESS: STREET 1: 7043 S 300 WEST CITY: MIDVALE STATE: UT ZIP: 84047 BUSINESS PHONE: 8015661200 RW 1 utmdrw20120202.htm utmdrw20120202.htm


 
 
February 2, 2012




VIA EDGAR


U.S. Securities and Exchange Commission
100 F. Street, N.E.
Washington, D.C. 20549

 
Re:
Utah Medical Products, Inc. (the “Company”)
 
 
Registration Statement on Form S-3 (File No. 333-153361)
 
 
Request for Withdrawal

Ladies and Gentlemen:

The Company hereby applies for withdrawal of its registration statement on Form S-3 (File No. 333-153361), which became effective upon its filing with the Securities and Exchange Commission (the “Commission”) on September 8, 2008, together with all exhibits thereto.  Pursuant to Rule 477 of the Securities Act of 1933, as amended (the “Securities Act”), the Company is withdrawing the Registration Statement because more than three years have passed since the initial effective date and the securities registered may no longer be bought or sold pursuant to Rule 415(a)(5) of the Securities Act.  No securities were sold in connection with the Registration Statement.

The Company also requests that all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use pursuant to Rule 457(p) of the Securities Act.

If you have questions related to this request, please call me at 801-569-4200 or call James R. Kruse of Kruse Landa Maycock & Ricks, LLC, at (801) 531-7090.

 
Sincerely,
   
 
Utah Medical Products, Inc.
   
 
/s/ Paul O. Richins
   
 
Paul O. Richins
 
Principal Financial Officer



7043 S 300 W, Midvale, Utah 84047 Ÿ Telephone (801) 566-1200 Ÿ Facsimile (801) 566-7305

GRAPHIC 2 logo.jpg begin 644 logo.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`! M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@`````` M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`0$! M`@$!`0("`@("!`,"`@("!00$`P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H* M"@H&"`L,"PH,"0H*"O_;`$,!`@("`@("!0,#!0H'!@<*"@H*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_``!$(`($` M>`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_ MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($ M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B M7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X MN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$` M`A$#$0`_`/W\KG_%OC37?#E_%8Z/\+M=U\/#YCS:3BQOUU*FP?&+Q1/ M?VBM:T7QAX:T_6+2W\%Z7(UIJ-HD\<N,UX]\"=#\*:!^Q MWX6TSPEX'4>(/&_VG2;R[T*RB74)+'[5.UT^\[2=D",%);Y7:/V%`'O7_"U_ M&6U7_P"&=?&6UL;6^WZ)@YZ8_P")CS2M\5?&JD!OV<_&8+'"@W^B-/%G_``H3PM\,KK3)KCQ3\/?B_HNB&PUBX%O)=0I.KV,DKKOV"2V>'+#= M\ROUQ7HGQ6UOXIZC\9_A%;^-?`.EZ59CQI.RW-CXC:[=I?[+O?D*&WCPN,G= MD\C&.:`/1?\`A:7C?_HW#QI_X':)_P#+&C_A:7C?_HW#QI_X':)_\L:I_M16 M,FM_!'5O"<&KS6$NOSV>D17MN<20&[NX;?>ONHD)'TKR#XC?%_QQ\4OV:O$O MP>L]6>Q\>:+H.J6_CB2T.'M190G,J>@O"8?+/>.>0CF,T`>RS?&/Q/;S"WG_ M`&?_`!:DAZ1OJ>AAC^!U*@?&3Q,US]B7X`>+3-G'E#5-#W9^G]I9KQ;X3:=8 M?$_]HOQCXLNO@WH7B>&YL?"MU_:6JS1"33EDTY9-T2O$Y)YW?*5Y4?4;_P"S M5\'OA3\1?`OC:7QW\/\`2-2EN/B9XD2:\NK)#/M&H2@8FQO0CL0P([8H`]/_ M`.%J^--_E_\`#.?C/=C.W[?HF<>N/[1J"/XT^(9M0?28?@+XK>[C7=):KJNA M&11ZE?[2R*^1+CXH_$S3_A=IWCBS\4WKZG%\)M7LK3Q"\Q:<:>/$EK:QWQ<_ MQBUQ)YAYX#YYK['T3X&_!CPS8:4VF^`M)C.ALLVGZ@]LIGB=5/[TSGYV8@DL MS$ELDG-`$0^*OC4N8Q^SGXSW``E?M^B9`.<'_D(^Q_*K_ACQ]XD\0ZJEA?\` MP<\1Z1`P;=J&H7>F/"A'\)%O>2ODGCA3SUQ7A?A7XC>(=$_:0T3XSZMINN6_ MA[XERR:"SW\2K9Q!2TFCRQ8_"WQ!\8_#G@'4_`OB._\9P:1&KQ+2>R@W M!)0)VFC^]M`*'"/%^O:Y=Z=-J6NM>-&U_FVN6LG MAF>YG7,L>@C+,2S,FQ`P!KC_'W[.GBK2/C;+X:^`-[JNA?8/AD9[6Y2 MYD6+5KIM5>:>UN;D@N'GW,6D5A(I?>.!BM/X*W_A_P`!?%)/BO;^`-3\/>#O M$'@2PTBTM[C3)0WAZ\L9YQ+8W"A2T8;SMRRGY'9&.[YE+`&I\1O$O[/&B^(O M$WQ/^*/@/6].\3>'[/2M7U72!/F2[BM;EA9W<(CE\J<)+*R%MP(SM<#Y0>K\ M9?$/P//XV\'CXO\`PS\0:')'KP_X1?6+]H6M$U&6&2%(G>WG?8[I(Z*)`%+, M`#NQ7CW[8NA>(OC/_P`)+\1_!/AK4IM$\.?#Z?3(+U+"0/J]W=7MK(T<$>W? M+'$D&XN!M+OA<[6QZ)\<]:M/VC/#6B?"KX6V>H7YNO%&F7>K:N=,G@M],M+2 MZCN9)#+*BJ9&\K8D:Y8E\X"@D`'=>&?$7@#]HOX?V'C6"PO3IUIKKW%M%&+"[\5&S M$5NT5G-;L+6.ZFDD"I*8G?;&I9L+Q-I M>N:R]MI4.D3R-JB3WUQ<6[VSJA219%E09W?*VX-MP:S/V9M,O?V4]8USP7\8 MK&>S37+?2K[3=>BM9)[65XM.@M9K1I8U8))$\#%5;&Y'!7/(``W4;3X7?`[0 M+;Q\/@O\4-"MC%I6EWGV+Q`L6YX)%L;2&5%O1YO\"AP"K+(&+')Q?CTGX<-? M:[X,T7X1?$"9WFDUCQ?X6M/$02.'[;/*Q+1I=[)3,4E?RHV.5'(&0IW_`-J^ M[E^(?[.D>H>$=)U&Z6X\4Z))#%_9LR3-&FK6Q:3RV4.%VJ6R0/E^;IS6'^TY M8>'QXMU+Q/\`#/7/%/A[XJ6&C1IHDFCV$S0>(!EG@M9D*-!_\`C!XM\&B6PT'PA-I$VGV=N&B.F.\9>W6W)$9!*(,' ML,=*YGP-X8^`OC;7_$OP'T3QEXIW^%1]CN_#-WXCN52"WEA`5X?GW20A7*`E MF",,87"UL_M;Z=XAUO\`9+\7:Y\5>,O!]XV@>-="\<7-UX2UN>!@DBM:6@>WF'66TFVE'4="`R_,@H M`U?B3XY^#'CS0+;X+W?A35-5NI];EM-(T#2@(;A9=,F1CLR M]0H!)VG:^"?PVT/PS+4[J1](U'Q`UQ9S27#>?+/$B3/&P9Y M&Z@%6W#`[^+_``5N_''@GXNQ?M#?%GX::IHUEK=OK6D:S"EK)*?$MMX8T"34;F2[@GEANQI%PMJ1#Y>\ M>M'_`.BH_$#_`,+:\_\`BZ/^&>M'_P"BH_$# M_P`+:\_^+KOG=(U+NP55&22<`"OSN_X*"_\`!3G4==O+[X(_LW:\UOIL9:#6 MO%5G)B2[/1HK9A]V/L9!RW\)"\L`>N_&C]I?]C_X&^+G\#>)_P!H/XCZAJ4& M1>0Z%XKO+I;5A_!(XD"A_5021W`KD/\`AOO]B7_HK?QE_P#!U>?_`!ZOSH9F M=B[L22+;60N=?O$CWM MTW-YIP/>OHC_`(9ZT?\`Z*C\0/\`PMKS_P"+K\GOV#?^3Q/AY_V,D/\`)J_: M"@#Y;_:3^,7[//[*OB?3_"?Q0^)?Q::ZU*P-W;'3/$UU,GE[V3DF9<'*GBO. M/^'@W[%G_12/C9_X/+C_`.2*X+_@MK_R6_PA_P!BHW_I3)7Q70!^C_AG]NS] MB;Q%KUMHD_QF^+VF+A=DF8J/?&!WP.:^E='^"7A#Q!I=O MK>@_&3QQ>V5U$)+:[M/'EU)'*AY#*RN0P/J*_$NO>OV,OV]/B5^RAKL6D333 M:SX.N)\ZAH$TN?)R?FEMR>(Y.Y'W7Z'G#``_4/\`X9ZT?_HJ/Q`_\+:\_P#B MZTO"7P@T[PAK<>N6WCKQ;?/&C*+;5O$UQXCX(/1D9>JNIR&4\@@BM^@`HHHH`***Y[XL?$;1/ MA%\--=^)WB)O]#T/3)KN9[-A1[L*`/D3_@K)^V?>>`M(/[-'PTU MN,"@#US]@W_D\3X>?]C)#_`":OV@K\7_V#?^3Q M/AY_V,D/\FK]H*`/S7_X+:_\EO\`"'_8J-_Z4R5\5U]J?\%M?^2W^$/^Q4;_ M`-*9*^*Z`"BMSP)\.O%GQ)O;_3?!VFF[N=.TFXU*>W0_.T$"[I"H_B(7+8ZD M`XYXK#H`^E/^";O[9%[^S9\4X_!GB[5"/!GB2Y2+4EE8[;"X/RI=+_=`X5_5 M.>2@K]9U974.C`@C((/!%?@)7ZZ_\$P?C=JGQK_93TUO$%PTVH^&+Q]$NIY& MRTR1)&\3GN?W4B*2>I0F@#Z'HHHH`*^,_P#@LU\8KWPA\&]$^$6G2@?\);>2 M27V#SY-JT+@?0NR_]\U]F5^:/_!;+7I[CX^^%/##$^79^#Q=(.VZ:ZG0_I`M M`'QC5_POXOTB_X+<_\DA\%?\`8R3?^DYK\W:`/7/V M#?\`D\3X>?\`8R0_R:OV@K\7_P!@W_D\3X>?]C)#_)J_:"@#\U_^"VO_`"6_ MPA_V*C?^E,E?%=?:G_!;7_DM_A#_`+%1O_2F2OBN@#Z;_P""1Z))^V1I\Y6<9_W!Z5 M\/5]'?\`!*+7)])_;;\-V$1.W5+#4;:7']T6"(H(SC^*.\NF;])5K]-:^'/^"UOPMU+6_`_A+XLZ;: M,\.AW%Q9ZE*HX1)S%Y1/_`T8?\"H`_.:OH'_`()>Z_;Z#^VQX0-TX5;Q;VU! M/]Y[27:/Q8`?C7S]6]\+/'VI_"SXDZ#\2-'!-SH>K6][$@.-_ER!BA]B`0?8 MT`?HO_P6G\,7VI_L\^'?$UJA:+2_%2K&%?C%XR\'^(_A_X MKU'P1XOTJ6RU/2KM[:^M9EPTVY>QU: M\6WNX3CE#"QW,P/'RA@>Q-?C)10![O\`\%#OVG]`_:D^/1\3>"XY?[!T;3TT M[29IHRCW*J[N\Q4\J&9S@'G:JY`)('A%%%`'UA_P1Q\,WFL?M7W&O11$P:1X M7NI9G[`R/'$H_'L?\%PO$%FNC?#[PJ&!N'NM0NV7NJ*L*#\RQ_[YKT/ M_@DK^S9J/P?^"5S\3_%NG-;ZQXT>*>"&5,/#8(#Y(.>AAWHGTOPK;KH]G(C95Y(V9IW'K^]9ESW$8-`'SI7T/_`,$K M-,N;_P#;B\(W4"Y6RM]2FFXZ*;"XC_\`0I%KYXK[0_X(J?#^;5_C;XG^)$L# M&WT3P\+1'QP)KF52.?79#)^=`'Z64444`%<9^T/\(]/^._P3\2?";4"J_P!L MZ8\5M*XXBN!AX9/^`R*C?A79T4`?@?X@T'5_"VO7OAG7[%[6^TZ[DMKRVE&& MBE1BKJ?<$$53K[I_X*Z_L@7>BZ^?VI/`.E%K#4"D/BV&%?\`CWN.%CNL#^%Q MA6/9PI_C./A:@#[B_P""5?[`I(_V:OBYK2V^E75P6\+:I=2`1VDSMEK5 MV/"H[$LI/`O7KM]J MAE8@1VN[_ELNP,V3\R`*,D,H`!\$?%WX$?%SX$>('\-_%;P)?Z/.'*Q2SQ9A MG`_BCE7*2#W4FN1K]\=:T+0_$FGOI'B+1K2_M)/]9:WMNLL;?56!!KSJ^_8I M_9)U*]-_=?L[>$C*QRWEZ/&BD_[J@#]*`/Q?T#P[X@\5ZM#H/A?0[O4;ZX;; M!9V-LTLLA]`J@DU]T_L/_P#!*36QK%E\5?VHM,CM[>W=9M/\(.0[S,.5:ZQD M*HZ^4"2>C8&5/W5X)^%WPU^&UJ;/X>^`-&T.(KAETG3(K?<_MV_ M%KXQ_!#]G?5/B+\%M%L[J_LI$%]<72ES8VS95KA(^DC*Q7AN`"6((4B@#A_^ M"BO[;NB_LT_#Z;X=>!-4C;QQK5H8[**W89TJW8$&Y?'W6QD1KW/S=%Y_)^22 M261I97+,Q)9F.22>YJ_XJ\5>)/''B*\\7>+];N=2U/4)S->WUW*7DF<]22?R M]@`!P*SZ`"OU>_X)+?!_4?AC^RM#XBURR$-YXNU2354#)AQ:[$B@!]00C2#V MFKX*_87_`&4]7_:J^-%KH-Q:RIX;TETNO$UZH("P!N(%;_GI(05'<#FVD<%M;0K%;P1(%2-%`"JH'0```"@":BBB@`HHHH`J:]H.B^* M=$N_#?B/2X+VPO[=X+RTN8PT32BQXAG_VN`97]P#A5_V4 M45PWP\_X)O\`P!^%?[1<'[0'@>VN+5;:"9K7PZ^'M;:Z?@3Q$_,@52X"'(!8 M$%=H%?0-`!1110`56UG1M+\1:/=:!KEA'=65];/;W=M,N4EB=2K(P[@@D'ZU M9HH`_%/]L+]G35?V8?CMJWPVN$E;3B_VK0+N3_EXLI"3&<]V7!1O]I#[5G_L MX?LU?$W]I_X@P>`_AUI1*@J^IZK,A^SZ?#GF21OSPH^9CP!UQ^K?[6G[%OPU M_:\MM!B\;ZA=Z?/H=\9%O=.5/.FMG'[RWRP(`8A.TKP.37<_"+X,_#7X% M>#8/`?PM\*V^E:=!RRQ#,D[XP9)'/S2.>[,2>W0`4`9/[-_[.GP^_9A^&5K\ M-?`%J2J'S=1U&91YU_<$`--(1]``O15``Z9KOJ**`"BBB@`HHHH`****`"BB 8B@`HHHH`****`"BBB@`HHHH`****`/_9 ` end